Morgan Stanley upgrades Befesa to “overweight” on strong cash flow, low valuation

Morgan Stanley has upgraded Befesa SA to "overweight" from "equal weight," raising its price target to €32, citing improved earnings visibility, accelerating deleveraging, and an attractive valuation that implies a 28% upside. The brokerage projects 2025 and 2026 EBITDA 7% above consensus, driven by favorable zinc dynamics and record-low treatment charges, forecasting net debt/EBITDA to fall to 2.2x by year-end 2025. Befesa, currently trading at a 23% discount to peers at 6x 2025e EV/EBITDA, offers defensive exposure to structural growth themes, with re-rating potential expected as leverage stabilizes, despite prioritizing deleveraging over immediate capital returns.

Analysis

Morgan Stanley has upgraded Befesa SA to “overweight,” raising its price target to €32 from €26, which implies a 28% upside from its recent closing price. The upgrade is driven by improved earnings visibility, an accelerating deleveraging path, and an attractive valuation. The brokerage's 2025-2026 EBITDA forecasts are 7% above consensus, supported by favorable zinc market dynamics and record-low 2025 zinc treatment charges of $80/t. Earnings visibility is significantly enhanced by hedges covering 60-70% of zinc exposure for 2025-2026 at prices near current spot levels. The company's financial discipline is evident in its plan to reduce net debt/EBITDA from 2.7x to 2.2x by year-end 2025, well within its 2.0-2.5x target range, supported by a capex cap of €100 million and strong free cash flow generation. Currently, Befesa trades at 6x 2025e EV/EBITDA, a 23% discount to its peers, presenting re-rating potential as the balance sheet strengthens. While near-term capital returns are limited to the stable 4.5-5% dividend yield due to the focus on deleveraging, the core business provides defensive exposure to structural growth themes in recycling.

Key Decisions for Investors

• Given the 28% implied upside, strong free cash flow projections, and a significant valuation discount to peers, investors could view this as a compelling entry point, with deleveraging serving as a key catalyst for a potential re-rating.
• It is crucial to monitor the company's progress toward its net debt/EBITDA target of 2.0-2.5x, as successful execution is fundamental to the investment thesis outlined by Morgan Stanley.
• While the 4.5-5% dividend yield is secure and covered by free cash flow, investors should not anticipate share buybacks or special dividends in the near term as management has explicitly prioritized debt reduction.
• The primary risks to watch are operational performance and profitability improvements at the U.S. and Chinese plants, as any underperformance could delay deleveraging and negatively impact sentiment.